Rhabdomyolysis is a rare complication of statin monotherapy. However the risk of rhabdomyolysis is much higher when patients are exposed to the combination of systemic fusidic acid (as fusidic acid hemihydrate/sodium fusidate; hereafter referred to simply as ‘fusidic acid’) and a statin, compared with exposure to a statin alone.
- Lithium-Prescribing & Monitoring (Best Practice Guidelines and Patient Information)
- IMSN Medication Safety Bulletin & other published material
- Direct Oral Anticoagulants (DOACs) (Safety Alert & Patient Resources)
- Electronic transmission of prescriptions: IMSN Position Paper
- Methotrexate (once weekly): Safety alert